Live feed
·
PRReleasevia Quantisnow
Freeline Therapeutics Holdings plc logo

Freeline to Present New Data on its Gaucher and Parkinson's Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
FRLN· Freeline Therapeutics Holdings plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FRLN (Freeline Therapeutics Holdings plc) and more on Quantisnow.